Welcome to Krystal Biotech’s Q3 2024 Earnings Conference Call
Meet the Team:
- Stéphane Paquette – VP, Corporate Development
- Krish Krishnan – Chairman and CEO
- Suma Krishnan – President, Research and Development
- Jennifer McDonough – SVP, Patient Access, Analytics and Operations
- Christine Wilson – SVP and Head, U.S. Sales and Marketing
- Kate Romano – CAO
Today’s conference call features an exciting lineup of speakers who will be sharing important insights into Krystal Biotech’s performance in the third quarter of 2024. From corporate development to research and development, we have a diverse team dedicated to driving the company’s success.
Conference Call Participants:
- Alec Stranahan – BOA
- Yigal Nochomovitz – Citigroup
- Ritu Baral – TD Cowen
- Sami Corwin – William Blair
- Gavin Clark-Gartner – Evercore ISI
- Dae Gon Ha – Stifel
- Debjit Chattopadhyay – Guggenheim Securities
- Andrea Newkirk – Goldman Sachs
The participation of esteemed analysts and investors further highlights the significance of today’s earnings call. We appreciate your interest in Krystal Biotech’s financial performance and growth prospects.
How this will impact me:
As an investor, the insights shared during Krystal Biotech’s Q3 2024 Earnings Conference Call can provide valuable information about the company’s financial health and future potential. Understanding the performance metrics and strategic direction of Krystal Biotech can help inform investment decisions and portfolio management strategies.
How this will impact the world:
Krystal Biotech’s advancements in biotechnology and healthcare can have far-reaching effects on the world. From innovative treatments to improved patient access, the company’s developments can contribute to the overall well-being of individuals globally. Through research and development efforts, Krystal Biotech is driving progress in the healthcare industry and shaping the future of medicine.
Conclusion:
Thank you for joining Krystal Biotech’s Q3 2024 Earnings Conference Call. The participation of our team members, conference call participants, and investors underscores the importance of transparency and communication in our journey towards growth and success. We look forward to continuing to drive innovation and make a positive impact on both individuals and the world as a whole.
